18 Followers on Owler
Cytokinetics is a California-based biopharmaceutical company that researches and develops muscle activators and muscle inhibitors to treat cardiovascular diseases...
Read moreCytokinetics is a California-based biopharmaceutical company that researches and develops muscle activators and muscle inhibitors to treat cardiovascular diseases...
Read more
1998
PublicIndependent CompanyNASDAQCYTK
News
Jan 30, 2023
BioSpace
Cytokinetics: Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant ProgramTotal of $100,000 Awarded to Five Patient Advocacy Organizations to Support Communications and Community Outreach
Jan 20, 2023
Nasdaq
Cytokinetics: Interesting CYTK Put And Call Options For March 17th
Jan 06, 2023
Seeking Alpha
Cytokinetics: Where To Now With Cytokinetics After The Omecamtiv Outcome?
Jan 04, 2023
BioSpace
Cytokinetics: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 04, 2023
Jan 03, 2023
Benzinga
Cytokinetics: Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Dec 14, 2022
MedicalMarketing& Media
Cytokinetics: FDA panel votes against approving Cytokinetics' heart failure drug
Dec 14, 2022
Medthority
Cytokinetics: FDA Advisory Committee negative for omecamtiv mecarbil for treatment ofheart failure with reduced ejection fraction
Dec 13, 2022
Advfn
Cytokinetics: Trading in Cytokinetics Shares Halted Ahead of FDA AdCom Meeting
Dec 13, 2022
PharmaLive
Cytokinetics: Cytokinetics' heart drug fails to secure FDA panel's support
Dec 10, 2022
Life Care News
Cytokinetics: Cytokinetics Announces Availability of Briefing Documents
Cytokinetics Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to Cytokinetics?
Cytokinetics Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$148.2M
Cytokinetics's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 18.8B. Over the last four quarters, Cytokinetics's revenue has decreased by 95.5%. Specifically, in Q3 2022's revenue was $2.5M; in Q2 2022, it was $89M; in Q1 2022, it was $1.1M; in Q4 2021, Cytokinetics's revenue was $55.6M.
Cytokinetics News
Cytokinetics Press Releases
Cytokinetics Videos
Cytokinetics Headquarters
Cytokinetics Summary
ABOUT
Overview
Cytokinetics is a California-based biopharmaceutical company that researches and develops muscle activators and muscle inhibitors to treat cardiovascular diseases. Cytokinetics was founded in 1998. Cytokinetics' headquarters is located in South San Fr...CEO
Cytokinetics's President & CEO, Robert Blum, currently has an approval rating of 89%. Cytokinetics's primary competitors are Amylyx, Orphazyme & MediciNova.Website
cytokinetics.comCompetitors
View 15 Cytokinetics competitors here.Acquisitions
There have been no acquisitions found related to CytokineticsInvestments
Recent investment data cannot be found related to CytokineticsFrequently Asked Questions about Cytokinetics
When was Cytokinetics founded?
Cytokinetics was founded in 1998Who is Cytokinetics's CEO?
Cytokinetics's CEO is Robert BlumHow much revenue does Cytokinetics generate?
Cytokinetics generates $148.2M in revenueHow much funding does Cytokinetics have?
Cytokinetics has historically raised $1B in funding
Where is Cytokinetics's headquarters?
Cytokinetics's headquarters is in South San Francisco California, USAHow many employees does Cytokinetics have?
Cytokinetics has 250 employeesWhat sector does Cytokinetics operate in?
Cytokinetics is in Biotechnology, PharmaceuticalsWho are Cytokinetics's competitors?
Cytokinetics's top competitors are Amylyx, Orphazyme, MediciNova